HK1201439A1 - Method of treating or reducing efp efp - Google Patents

Method of treating or reducing efp efp

Info

Publication number
HK1201439A1
HK1201439A1 HK15101853.7A HK15101853A HK1201439A1 HK 1201439 A1 HK1201439 A1 HK 1201439A1 HK 15101853 A HK15101853 A HK 15101853A HK 1201439 A1 HK1201439 A1 HK 1201439A1
Authority
HK
Hong Kong
Prior art keywords
efp
treating
reducing
reducing efp
efp efp
Prior art date
Application number
HK15101853.7A
Other languages
English (en)
Chinese (zh)
Inventor
Susan G Emeigh Hart
Original Assignee
Auxilium Int Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auxilium Int Holdings Inc filed Critical Auxilium Int Holdings Inc
Publication of HK1201439A1 publication Critical patent/HK1201439A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24003—Microbial collagenase (3.4.24.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15101853.7A 2011-10-21 2015-02-23 Method of treating or reducing efp efp HK1201439A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161549863P 2011-10-21 2011-10-21
PCT/US2012/061063 WO2013059619A1 (en) 2011-10-21 2012-10-19 Method of treating or reducing efp

Publications (1)

Publication Number Publication Date
HK1201439A1 true HK1201439A1 (en) 2015-09-04

Family

ID=48141393

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15101853.7A HK1201439A1 (en) 2011-10-21 2015-02-23 Method of treating or reducing efp efp

Country Status (15)

Country Link
US (1) US20140335072A1 (da)
EP (2) EP3581199B1 (da)
JP (4) JP2014530873A (da)
AU (5) AU2012325941A1 (da)
BR (1) BR112014009785B1 (da)
CA (1) CA2852942C (da)
DK (2) DK3581199T3 (da)
ES (2) ES2953560T3 (da)
FI (1) FI3581199T3 (da)
HK (1) HK1201439A1 (da)
HU (2) HUE044650T2 (da)
MX (2) MX2014004792A (da)
PL (1) PL3581199T3 (da)
PT (2) PT3581199T (da)
WO (1) WO2013059619A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ766918A (en) 2012-01-12 2023-03-31 Auxilium Int Holdings Inc Clostridium histolyticum enzymes and methods for the use thereof
CA2872227A1 (en) 2012-05-01 2013-11-07 Proteolease Ltd. Methods for extracting a tooth
EP3834840A1 (en) 2013-03-15 2021-06-16 BioSpecifics Technologies Corporation Treatment method and product for uterine fibroids using purified collagenase
CN103751102A (zh) 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
US11123280B2 (en) 2017-03-01 2021-09-21 Endo Ventures Limited Method of assessing and treating cellulite
US11473074B2 (en) * 2017-03-28 2022-10-18 Endo Global Aesthetics Limited Method of producing collagenase
WO2020021332A2 (en) * 2018-07-12 2020-01-30 Endo Global Aesthetics Limited Injection techniques for the treatment of cellulite
WO2020021330A2 (en) * 2018-07-12 2020-01-30 Endo Global Aesthetics Limited Injection techniques for the treatment of cellulite
WO2020023406A1 (en) * 2018-07-23 2020-01-30 Nc8, Inc. Cellulite treatment system and methods
CN113015514A (zh) * 2018-09-18 2021-06-22 恩多全球美学有限公司 用于治疗皮下脂肪团的组合物和方法
CN113382714A (zh) * 2019-01-06 2021-09-10 恩多全球美学有限公司 胶原酶制剂及其制备方法
CA3157517A1 (en) 2019-10-15 2021-04-22 The Johns Hopkins University Treatment of uterine fibroids using purified collagenase
US20210244642A1 (en) * 2020-02-10 2021-08-12 Simeon Wall, Jr. Cellulite eradication methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524065A (en) * 1983-08-04 1985-06-18 Bio-Specifics N.V. Method for the prevention and treatment of scars with enzymes
US4645668A (en) 1983-08-04 1987-02-24 Biospecifics, Nv Method for the prevention and treatment of scars with enzymes
US6958150B2 (en) * 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
DK2422789T3 (da) * 2004-05-19 2018-02-26 Los Angeles Biomedical Res Inst Harbor Ucla Medical Ct Injicerbar sammensætning omfattende natriumdeoxycholat
US20070224184A1 (en) 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
US7811560B2 (en) * 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
CN101678088B (zh) * 2007-02-14 2014-01-08 友莱尔皮肤产品有限责任公司 修饰的突变体胶原蛋白酶及其在脂肪溶解和疤痕减少中的应用

Also Published As

Publication number Publication date
HUE044650T2 (hu) 2019-11-28
PL3581199T3 (pl) 2023-09-11
NZ737403A (en) 2020-05-29
DK3581199T3 (da) 2023-09-04
AU2020200763A1 (en) 2020-02-20
JP2018027968A (ja) 2018-02-22
EP2768523A4 (en) 2015-04-22
EP2768523B1 (en) 2019-05-22
CA2852942A1 (en) 2013-04-25
DK2768523T3 (da) 2019-07-22
BR112014009785B1 (pt) 2020-06-30
PT3581199T (pt) 2023-08-31
NZ769098A (en) 2022-03-25
PT2768523T (pt) 2019-08-29
AU2017248451A1 (en) 2017-11-02
MX2014004792A (es) 2015-08-14
JP2020158521A (ja) 2020-10-01
EP3581199A1 (en) 2019-12-18
FI3581199T3 (fi) 2023-08-18
NZ624057A (en) 2016-08-26
AU2022202987A1 (en) 2022-05-26
NZ759819A (en) 2020-11-27
MX2019007779A (es) 2019-09-04
EP3581199B1 (en) 2023-05-31
AU2017248451B2 (en) 2019-11-14
CA2852942C (en) 2023-01-10
US20140335072A1 (en) 2014-11-13
ES2953560T3 (es) 2023-11-14
EP2768523A1 (en) 2014-08-27
WO2013059619A1 (en) 2013-04-25
AU2012325941A1 (en) 2014-05-15
JP2022123073A (ja) 2022-08-23
HUE063599T2 (hu) 2024-01-28
JP2014530873A (ja) 2014-11-20
BR112014009785A2 (pt) 2017-04-25
ES2741476T3 (es) 2020-02-11
NZ722722A (en) 2019-05-31
AU2020200763B2 (en) 2022-05-26
AU2016202026A1 (en) 2016-04-21
BR112014009785A8 (pt) 2020-02-27

Similar Documents

Publication Publication Date Title
EP2773754A4 (en) Methods of Treatment
GB201110095D0 (en) Method of treatment
HK1201439A1 (en) Method of treating or reducing efp efp
EP2723384A4 (en) TREATMENT OF PROTEINOPATHIES
EP2717855A4 (en) PROCESSING METHODS
GB201018147D0 (en) Method of treatment
GB201003920D0 (en) Method of treatment
SI2701707T1 (sl) Metoda za zdravljenje diskinezije
IL229706A0 (en) A method for treating the effects of a stroke
SG11201400256PA (en) Water treatment method
EP2531259A4 (en) METHOD FOR TREATING MULTIPLE SCLEROSIS
EP2709466A4 (en) PROCESS FOR TREATING HONEY
EP2585103A4 (en) METHOD OF TREATMENT
GB201018149D0 (en) Method of treatment
GB201105523D0 (en) Treatment method
EP2791324A4 (en) PROCESSING METHOD
GB201020015D0 (en) Method of treatment
GB201102475D0 (en) Method of reducing offset
GB201111530D0 (en) Method of treatment
GB201109509D0 (en) Method of treatment
GB201109266D0 (en) Method of treatment
GB201103044D0 (en) Method of treatment
GB201005071D0 (en) Method of treatment
GB201003917D0 (en) Method of treatment
GB201000318D0 (en) Method of treatment